Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:9469276.
doi: 10.1155/2016/9469276. Epub 2016 May 9.

Chinese Herbal Medicine as an Adjunctive Therapy for Breast Cancer: A Systematic Review and Meta-Analysis

Libing Zhu  1 , Lingru Li  1 , Yingshuai Li  1 , Ji Wang  1 , Qi Wang  1
Affiliations
Review

Chinese Herbal Medicine as an Adjunctive Therapy for Breast Cancer: A Systematic Review and Meta-Analysis

Libing Zhu et al. Evid Based Complement Alternat Med. 2016.

Abstract

Chinese herbal medicine (CHM) has been widely used as an adjunctive therapy for breast cancer, while its efficacy remains unexplored. The purpose of this study is to evaluate the efficacy of CHM combined with chemotherapy for breast cancer. The study results showed that CHM combined with chemotherapy significantly increased tumor response and KPS as compared to using chemotherapy alone (RR = 1.36; 95% CI = 1.24-1.48; P < 0.00001; RR = 1.38; 95% CI = 1.26-1.52; P < 0.00001, resp.). Besides, CHM as an adjunctive therapy significantly reduced the nausea and vomiting at toxicity grade of III-IV (RR = 0.37; 95% CI = 0.27-0.52; P < 0.00001). Moreover, the combined therapy significantly prevented the decline of WBC in patients under chemotherapy at toxicity grade of III-IV (RR = 0.49; 95% CI = 0.34-0.69; P < 0.00001) and prevented the decline of platelet at toxicity grade of III-IV or I-IV (RR = 0.29; 95% CI = 0.12-0.73; P = 0.008; RR = 0.77; 95% CI = 0.63-0.94; P = 0.009, resp.). This study suggests that CHM combined with chemotherapy in comparison with chemotherapy alone can significantly enhance tumor response, improve KPS, and alleviate toxicity induced by chemotherapy in breast cancer patients. However, a firm conclusion could not be reached due to the lack of high quality trials and large-scale RCTs, so further trials with higher quality and larger scale are needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flow diagram.
Figure 2
Figure 2
Risk of bias graph.
Figure 3
Figure 3
Risk of bias summary.
Figure 4
Figure 4
Tumor response.
Figure 5
Figure 5
Quality of life: KPS.
Figure 6
Figure 6
Reduction of adverse effects.
Figure 7
Figure 7
Immunoregulation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Parkin D. M. Global cancer statistics in the year 2000. The Lancet Oncology. 2001;2(9):533–543. doi: 10.1016/s1470-2045(01)00486-7. - DOI - PubMed
    1. Siegel R. L., Miller K. D., Jemal A. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians. 2016;66(1):7–30. doi: 10.3322/caac.21332. - DOI - PubMed
    1. Sotiriou C., Neo S.-Y., McShane L. M., et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(18):10393–10398. doi: 10.1073/pnas.1732912100. - DOI - PMC - PubMed
    1. Sørlie T., Perou C. M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(19):10869–10874. doi: 10.1073/pnas.191367098. - DOI - PMC - PubMed
    1. Cui Y., Shu X.-O., Gao Y., et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Research and Treatment. 2004;85(3):263–270. doi: 10.1023/b:brea.0000025422.26148.8d. - DOI - PubMed

LinkOut - more resources